Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists

Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists

US Patent 7288517 · Granted Oct 30, 2007

Estimated economic value: $1,187,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising P-hydroxybenzylamine2018
LHRH—antagonists in the treatment of fertility disorders2015
Application of initial doses of LHRH analogues and maintenance doses of LHRH ant2014
Use of perifosine in combination with antimetabolites for the treatment of benig2013
Use of perifosine in combination with antimetabolites for the treatment of benig2013
Use of alkylphosphocholines in combination with antitumor medications for the tr2013
Use of alkylphosphocholines in combination with antimetabolites for the treatmen2013
Method for a programmed controlled ovarian stimulation protocol2012
Process for preventing protozoal diseases2011
Injection solution of an LHRH antagonist2010
Method for the therapeutic management of endometriosis2010
Oligopeptide lyophilisate, their preparation and use2009